Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | HPGD | P15428 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.33 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.33 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22073886 | 0.96 | PIM3 (0.40) | GPR3PIM3CYP1A2KDM4ELIMK1 | |
| SCHEMBL26363520 | 0.95 | PIM3 (0.40) | GPR3PIM3CYP1A2KDM4ELIMK1 | |
| SCHEMBL24808288 | 0.94 | GPR3 (0.40) | GPR3PIM3CYP1A2KDM4ELIMK1 | |
| SCHEMBL22161555 | 0.93 | PIM3 (0.40) | GPR3PIM3CYP1A2KDM4ELIMK1 | |
| SCHEMBL20561300 | 0.93 | GPR3 (0.41) | GPR3PIM3CYP1A2KDM4ELIMK1 | |
| SCHEMBL25706495 | 0.92 | ALDH1A1 (0.40) | GPR3PIM3CYP1A2KDM4ELIMK1 | |
| SCHEMBL23437787 | 0.92 | GPR3 (0.38) | GPR3PIM3CYP1A2KDM4ELIMK1 | |
| SCHEMBL23437160 | 0.92 | PIM3 (0.42) | GPR3PIM3CYP1A2KDM4ELIMK1 | |
| SCHEMBL24184331 | 0.92 | PIM3 (0.42) | GPR3PIM3CYP1A2KDM4ELIMK1 | |
| SCHEMBL24297042 | 0.92 | GPR3 (0.45) | GPR3PIM3CYP1A2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
| US-11367839-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-06-21 | — | — | US | disclosed |
| US-20220037594-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-02-03 | — | — | US | disclosed |
| US-20220029104-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-01-27 | — | — | US | disclosed |
| WO-2020130389-A1 | ORGANIC ELECTRONIC DEVICE, AND ELECTRONIC APPARATUS THEREOF | 덕산네오룩스 주식회사 | 2020-06-25 | — | — | WO | disclosed |
| WO-2020130392-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING ORGANIC ELECTRIC ELEMENT | 덕산네오룩스 주식회사 | 2020-06-25 | — | — | WO | disclosed |
| WO-2020130394-A1 | ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2020-06-25 | — | — | WO | disclosed |
| US-20200203623-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
| WO-2020116822-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF | 덕산네오룩스 주식회사 | 2020-06-11 | — | — | WO | disclosed |
| WO-2020116816-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING ORGANIC ELECTRIC ELEMENT | 덕산네오룩스 주식회사 | 2020-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11367839-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | ORAI2, KCNJ2, OR10J3 | GPR3 4757/4885PIM3 2449/4885CYP1A2 879/4885 |
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | GPR3 4747/4885PIM3 2567/4885CYP1A2 762/4885 |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | PIEZO1, ORAI2, OCIAD1 | GPR3 4734/4885PIM3 2396/4885CYP1A2 844/4885 |
| US-20200203623-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | GPX1, PIEZO1, ORAI2 | GPR3 4392/4885PIM3 1019/4885CYP1A2 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.